Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
{{output}}
Background: Diabetic neuropathy (DN) affects up to half of individuals with type 1 and type 2 diabetes. Despite evidence that improving metabolic and cardiovascular health can slow its progression, DN remains a significant clinic... ...
